Ranolazine: Multifaceted Role beyond Coronary Artery Disease, a Recent Perspective

Area of Science:

• Cardiology
• Pharmacology
• Electrophysiology

Background:

• Ranolazine is an antianginal medication targeting the late sodium current.
• It is primarily used for stable coronary artery disease and atrial fibrillation (AF).

Purpose of the Study:

• To review the established and emerging clinical applications of ranolazine.
• To highlight its mechanisms of action and expanding therapeutic potential.

Main Methods:

• Review of existing clinical trials and pharmacological studies on ranolazine.
• Analysis of ranolazine's effects on ion channels, myocardial function, and clinical outcomes.

Main Results:

• Ranolazine reduces myocardial wall tension and improves coronary blood flow.
• It is effective in AF, post-CABG surgery, and shows anti-glycemic effects.
• Investigational uses include pulmonary arterial hypertension, cardiotoxicity, and peripheral arterial disease.

Conclusions:

• Ranolazine's established role in angina and AF is supported by its mechanism of action.
• Growing evidence suggests broader applications, warranting further clinical investigation.